All Stories

  1. Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma
  2. Age-Dependent Levels of Protein Kinase Cs in Brain: Reduction of Endogenous Mechanisms of Neuroprotection
  3. Nutrition and Female Fertility: An Interdependent Correlation
  4. Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine
  5. Rare Dihydropyrimidine Dehydrogenase Variants and Toxicity by Floropyrimidines: A Case Report
  6. Bone Metastases from Solid Tumors
  7. Gene Fusion in NSCLC
  8. Molecular Assessment of Ovarian Cancer and Translation to Clinical Management
  9. Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors
  10. Redox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions
  11. SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
  12. Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels
  13. Genetic bases of the nutritional approach to migraine
  14. Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family
  15. Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
  16. Animal-type melanoma: dog or wolf? A review of the literature and a case report
  17. Sex-Genetic Interaction in the Risk for Cerebrovascular Disease
  18. Immune‑related adverse events during anticancer immunotherapy: Pathogenesis and management (Review)
  19. Ovarian cancer: Novel molecular aspects for clinical assessment
  20. Procoagulant imbalance in premenopausal women with chronic migraine
  21. Desmoid Tumors in Familial Adenomatous Polyposis
  22. Characterization of a Rare Nonpathogenic Sequence Variant (c.1905C>T) of the Dihydropyrimidine Dehydrogenase Gene (DPYD)
  23. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA)
  24. ALK gene alterations in cancer: biological aspects and therapeutic implications
  25. Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development
  26. Characterization of a Rare Nonpathogenic Methylenetetrahydrofolatereductase (MTHFR) Gene Mutation p.Lys215del in a Southern Italian family
  27. The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators
  28. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations
  29. Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition
  30. Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases
  31. O039. Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana
  32. VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients
  33. Comparison of therapy with Ticagrelor, Prasugrel or high Clopidogrel dose in PCI patients with high on treatment platelet reactivity and genotype variation. TRIPLETE RESET trial
  34. DNA fingerprinting and Biobanking
  35. Sample PREanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols
  36. Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study
  37. Progesterone Receptor Gene (PROGINS) Polymorphism Correlates with Late Onset of Migraine
  38. IsSOD2Ala16Val Polymorphism Associated with Migraine with Aura Phenotype?
  39. Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity
  40. Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress
  41. Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors
  42. Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection
  43. Familial occurrence and heritable connective tissue disorders in cervical artery dissection
  44. Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study
  45. Obesity and colorectal cancer: Role of adipokines in tumor initiation and progression
  46. Diagnostic Procedures for Paraffin-Embedded Tissues Analysis in Pharmacogenomic Studies
  47. EHMTI-0241. Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study
  48. An International Ki67 Reproducibility Study
  49. Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B)
  50. An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies
  51. Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease
  52. Age-related reduction of cerebral ischemic preconditioning: myth or reality?
  53. TNF-  gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy
  54. Impact of chemotherapy on activated protein C-dependent thrombin generation-Association with VTE occurrence
  55. Prion Protein Gene M129V Polymorphism and Variability in Age at Migraine Onset
  56. Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome
  57. Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM)
  58. Research Highlights: Highlights from the latest articles in stroke pharmacogenomics
  59. A reliable and reproducible technique for DNA fingerprinting in biorepositories: a pilot study from BioBIM
  60. Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning
  61. Pharmacodynamic Effect of Switching Therapy in Patients With High On-Treatment Platelet Reactivity and Genotype Variation With High Clopidogrel Dose Versus Prasugrel: The RESET GENE Trial
  62. Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy
  63. 730 Analysis of EMSY in Italian Male Breast Cancer Patients
  64. Brachyury, a Driver of the Epithelial-Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer
  65. Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer
  66. Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies
  67. Impact of Statins on the Coagulation Status of Type 2 Diabetes Patients Evaluated by a Novel Thrombin-Generation Assay
  68. Migraine in cervical artery dissection and ischemic stroke patients
  69. Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments
  70. Thrombolysis in Cervical Artery Dissection - Data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database
  71. An AT-rich region in the APC gene may cause misinterpretation of familial adenomatous polyposis molecular screening
  72. Factor Seven Activating Protease Activity Levels in Women With Recurrent Pregnancy Loss
  73. Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer
  74. Impact of preanalytical handling and timing for peripheral blood mononuclear cells isolation and RNA studies: the experience of the Interinstitutional Multidisciplinary BioBank (BioBIM)
  75. SPRECware: software tools for Standard PREanalytical Code (SPREC) labeling – effective exchange and search of stored biospecimens
  76. Gender and cervical artery dissection
  77. Platinum-Based Compounds and Risk for Cardiovascular Toxicity in the Elderly: Role of the Antioxidants in Chemoprevention
  78. Importance of haplotype analysis in association studies considering VEGF promoter polymorphisms
  79. PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability
  80. VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea
  81. PRKCSH GAG trinucleotide repeat is a mutational target in gastric carcinomas with high-level microsatellite instability
  82. Preanalytical Procedures for DNA Studies: The Experience of the Interinstitutional Multidisciplinary BioBank (BioBIM)
  83. RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank
  84. Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab
  85. Traditional molecular markers and response to adjuvant endocrine or trastuzumab-based therapies
  86. VEGF-A gene promoter polymorphisms and microvascular complications in patients with essential hypertension
  87. TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women
  88. Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients
  89. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer
  90. Predictive value of thrombopath determination in women with infertility and pregnancy complications
  91. Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer
  92. Laparoscopic resection of sporadic synchronous gastric and jejunal gastrointestinal stromal tumors: Report of a case
  93. Chemoprevention of Colonic Cancer Is There a Foreseeable Future?
  94. Mismatch of neurophysiological findings in partial recovery of consciousness: a case report
  95. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients
  96. 543 POSTER Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship?
  97. 505 POSTER Serum adipokine levels in colorectal cancer patients
  98. Prognostic Value of Carcinoembryonic Antigen and Vascular Endothelial Growth Factor Tumor Tissue Content in Colorectal Cancer
  99. Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department
  100. PO-05 Determinants of homocysteine levels in colorectal and breast cancer patients
  101. PO-32 Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer
  102. Heterodimers Based on CoPt3−Au Nanocrystals with Tunable Domain Size
  103. Variation of the insulin receptor substrate gene (IRS-1) in African Pygmies and Bantus
  104. Mitochondrial DNA from Prehistoric Canids Highlights Relationships Between Dogs and South-East European Wolves
  105. Soluble CD40 Ligand Plasma Levels in Lung Cancer
  106. Prognostic value of soluble P-selectin levels in colorectal cancer
  107. Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer
  108. Correlations between Phenotype and Microsatellite Instability in HNPCC: Implications for Genetic Testing
  109. Taphonomy of the fossil hominid bones from the Acheulean site of Castel di Guido near Rome, Italy
  110. Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes
  111. Mutational analysis of OB gene in obese and type 2 diabetes affected subjects.
  112. Microsatellite instability in thyroid tumours and tumour-like lesions
  113. Setting cutoff concentrations for immunoassay screening of postmortem blood
  114. Transcripts with splicings of exons 15 and 16 of the hMLH1 gene in normal lymphocytes: implications in RNA-based mutation screening of hereditary non-polyposis colorectal cancer
  115. Origin and Gender Determination of Dried Blood on a Statue of the Virgin Mary
  116. Transcript dosage effect in familial adenomatous polyposis: Model offered by two kindreds with exon 9 APC gene mutations
  117. Transcript dosage effect in familial adenomatous polyposis: Model offered by two kindreds with exon 9APC gene mutations
  118. The 72-kDa and the 92-kDa gelatinases, but not their inhibitors TIMP-1 and TIMP-2, are expressed in early psoriatic lesions
  119. Use of a multiplex polymerase chain reaction assay in the sex typing of DNA extracted from archaeological bone
  120. Use of a multiplex polymerase chain reaction assay in the sex typing of DNA extracted from archaeological bone
  121. Microsatellite instability in sporadic mucinous colorectal carcinomas: relationship to clinico-pathological variables
  122. Microsatellite instability in sporadic mucinous colorectal carcinomas: relationship to clinico‐pathological variables
  123. Microsatellite instability in early gastric cancer
  124. Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis: Novel criteria of assessment and correlations with constitutional adenomatous polyposis coli gene mutations
  125. Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis: Novel criteria of assessment and correlations with constitutional adenomatous polyposis coli gene mutations
  126. Microsatellite alterations pathological aspects of breast cancer
  127. Novel allele of the hMLH1 gene bearing a TTC deletion in the 3' untranslated region
  128. Genetic instability in early gastric cancer
  129. Microsatellite instability and pathological aspects of breast cancer
  130. Alterations of DNA-repeats in human pancreatic cancer
  131. Novel mutations and inactivation of both alleles of the APC gene in desmoid tumors
  132. Multiplex PCR analysis and genotype-phenotype correlations of frequentAPC mutations
  133. Analysis of adenomatous polyposis coli gene in thyroid tumours
  134. A novel deletion in exon 15 of the adenomatous polyposis coli gene in an Italian kindred
  135. A novel mutation at the splice junction of exon 9 of the APC gene in familial adenomatous polyposis